About this data
What it is
When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
Who files it
The insider, usually through the company, within two business days of the trade.
How current
We collect new filings throughout the day on SEC business days.
Worth knowing
Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.

All of this comes from public filings.

Open-market trades per day, last 30 days

05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0
05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0

Purchases Sales

By trade date. Insiders have two business days to file, so the most recent days fill in later.

Latest open-market insider trades

Reset

Showing: ticker KURA

Latest open-market insider trades
TradedInsiderCompanyTypeSharesPriceValueFiling
Sep 29, 2026Kathleen Ford
Chief Operating Officer
KURA
Kura Oncology, Inc.
Sale3,668$10.75$39.4K SaleForm 4 ↗
Sep 29, 2026Mollie Leoni
Chief Medical Officer
KURA
Kura Oncology, Inc.
Sale28,802$10.75$309.6K SaleForm 4 ↗
Sep 29, 2026Brian T. Powl
Chief Commercial Officer
KURA
Kura Oncology, Inc.
Sale15,430$10.75$165.9K SaleForm 4 ↗
Sep 28, 2026Teresa Brophy Bair
Chief Legal Officer
KURA
Kura Oncology, Inc.
Sale8,442$10.50$88.6K SaleForm 4 ↗
Sep 28, 2026Kathleen Ford
Chief Operating Officer
KURA
Kura Oncology, Inc.
Sale6,906$10.50$72.5K SaleForm 4 ↗
Sep 28, 2026Mollie Leoni
Chief Medical Officer
KURA
Kura Oncology, Inc.
Sale12,448$10.50$130.7K SaleForm 4 ↗
Sep 28, 2026Thomas James Doyle
SVP, Finance & Accounting
KURA
Kura Oncology, Inc.
Sale4,607$10.50$48.4K SaleForm 4 ↗
Sep 28, 2026Brian T. Powl
Chief Commercial Officer
KURA
Kura Oncology, Inc.
Sale8,000$10.56$84.5K SaleForm 4 ↗
Sep 28, 2026Brian T. Powl
Chief Commercial Officer
KURA
Kura Oncology, Inc.
Sale9,020$10.50$94.7K SaleForm 4 ↗
Sep 24, 2026Francis Burrows
Chief Scientific Officer
KURA
Kura Oncology, Inc.
Sale20,726$10.83$224.5K SaleForm 4 ↗
Aug 24, 2026Troy Edward Wilson
President and CEO, Director
KURA
Kura Oncology, Inc.
Buy100,000$12.39$1.2M BuyForm 4 ↗
Aug 21, 2026Brian T. Powl
Chief Commercial Officer
KURA
Kura Oncology, Inc.
Sale4,345$11.89$51.7K SaleForm 4 ↗
Aug 19, 2026Teresa Brophy Bair
Chief Legal Officer
KURA
Kura Oncology, Inc.
Sale31,487$12.63$397.7K SaleForm 4 ↗
Aug 17, 2026Troy Edward Wilson
President and CEO, Director
KURA
Kura Oncology, Inc.
Buy100,000$11.12$1.1M BuyForm 4 ↗
Jun 18, 2026Mollie Leoni
Chief Medical Officer
KURA
Kura Oncology, Inc.
Sale84,929$9.82$834.0K SaleForm 4 ↗
May 21, 2026Brian T. Powl
Chief Commercial Officer
KURA
Kura Oncology, Inc.
Sale10,000$11.00$110.0K SaleForm 4 ↗
May 19, 2026Kathleen Ford
Chief Operating Officer
KURA
Kura Oncology, Inc.
Sale2,257$9.08$20.5K SaleForm 4 ↗
May 19, 2026Brian T. Powl
Chief Commercial Officer
KURA
Kura Oncology, Inc.
Sale339$9.21$3,122 SaleForm 4 ↗
May 18, 2026Teresa Brophy Bair
Chief Legal Officer
KURA
Kura Oncology, Inc.
Sale2,256$9.38$21.2K SaleForm 4 ↗
Jan 27, 2026Francis Burrows
Chief Scientific Officer
KURA
Kura Oncology, Inc.
Sale1,311$8.46$11.1K SaleForm 4 ↗
Jan 27, 2026Brian T. Powl
Chief Commercial Officer
KURA
Kura Oncology, Inc.
Sale1,572$8.46$13.3K SaleForm 4 ↗
Jan 27, 2026Brian T. Powl
Chief Commercial Officer
KURA
Kura Oncology, Inc.
Sale4,842$8.46$41.0K SaleForm 4 ↗
Jan 27, 2026Kathleen Ford
Chief Operating Officer
KURA
Kura Oncology, Inc.
Sale1,813$8.46$15.3K SaleForm 4 ↗
Jan 27, 2026Mollie Leoni
Chief Medical Officer
KURA
Kura Oncology, Inc.
Sale1,341$8.46$11.3K SaleForm 4 ↗
Jan 27, 2026Mollie Leoni
Chief Medical Officer
KURA
Kura Oncology, Inc.
Sale951$8.46$8,045 SaleForm 4 ↗
Jan 27, 2026Mollie Leoni
Chief Medical Officer
KURA
Kura Oncology, Inc.
Sale2,233$8.46$18.9K SaleForm 4 ↗
Jan 27, 2026Mollie Leoni
Chief Medical Officer
KURA
Kura Oncology, Inc.
Sale3,655$8.46$30.9K SaleForm 4 ↗
Jan 27, 2026Thomas James Doyle
SVP, Finance & Accounting
KURA
Kura Oncology, Inc.
Sale881$8.46$7,453 SaleForm 4 ↗
Jan 27, 2026Thomas James Doyle
SVP, Finance & Accounting
KURA
Kura Oncology, Inc.
Sale2,226$8.46$18.8K SaleForm 4 ↗
Jan 27, 2026Thomas James Doyle
SVP, Finance & Accounting
KURA
Kura Oncology, Inc.
Sale695$8.46$5,880 SaleForm 4 ↗
Jan 27, 2026Thomas James Doyle
SVP, Finance & Accounting
KURA
Kura Oncology, Inc.
Sale1,114$8.46$9,424 SaleForm 4 ↗
Jan 27, 2026Thomas James Doyle
SVP, Finance & Accounting
KURA
Kura Oncology, Inc.
Sale2,226$8.46$18.8K SaleForm 4 ↗
Jan 27, 2026Teresa Brophy Bair
Chief Legal Officer
KURA
Kura Oncology, Inc.
Sale4,777$8.46$40.4K SaleForm 4 ↗
Jan 27, 2026Teresa Brophy Bair
Chief Legal Officer
KURA
Kura Oncology, Inc.
Sale2,335$8.46$19.8K SaleForm 4 ↗
Jan 27, 2026Teresa Brophy Bair
Chief Legal Officer
KURA
Kura Oncology, Inc.
Sale4,096$8.46$34.7K SaleForm 4 ↗
Dec 18, 2025Francis Burrows
Chief Scientific Officer
KURA
Kura Oncology, Inc.
Sale23,726$9.78$232.0K SaleForm 4 ↗
Dec 9, 2025Faheem Hasnain
Director
KURA
Kura Oncology, Inc.
Sale10,000$10.98$109.8K SaleForm 4 ↗
Nov 14, 2025Teresa Brophy Bair
Chief Legal Officer
KURA
Kura Oncology, Inc.
Sale8,804$11.18$98.4K SaleForm 4 ↗
Nov 14, 2025Brian T. Powl
Chief Commercial Officer
KURA
Kura Oncology, Inc.
Sale8,887$11.18$99.4K SaleForm 4 ↗
Nov 14, 2025Mollie Leoni
Chief Medical Officer
KURA
Kura Oncology, Inc.
Sale15,485$11.18$173.1K SaleForm 4 ↗
Nov 14, 2025Thomas James Doyle
SVP, Finance & Accounting
KURA
Kura Oncology, Inc.
Sale4,539$11.18$50.7K SaleForm 4 ↗
Nov 14, 2025Kathleen Ford
Chief Operating Officer
KURA
Kura Oncology, Inc.
Sale6,902$11.18$77.2K SaleForm 4 ↗
Sep 29, 2025Brian T. Powl
Chief Commercial Officer
KURA
Kura Oncology, Inc.
Sale8,891$8.94$79.5K SaleForm 4 ↗
Sep 29, 2025Teresa Brophy Bair
Chief Legal Officer
KURA
Kura Oncology, Inc.
Sale8,805$8.94$78.7K SaleForm 4 ↗
Sep 29, 2025Kathleen Ford
Chief Operating Officer
KURA
Kura Oncology, Inc.
Sale6,892$8.94$61.6K SaleForm 4 ↗
Sep 29, 2025Mollie Leoni
Chief Medical Officer
KURA
Kura Oncology, Inc.
Sale12,314$8.94$110.1K SaleForm 4 ↗
Sep 29, 2025Troy Edward Wilson
President and CEO, Director
KURA
Kura Oncology, Inc.
Sale36,615$8.94$327.3K SaleForm 4 ↗
Sep 29, 2025Thomas James Doyle
SVP, Finance & Accounting
KURA
Kura Oncology, Inc.
Sale4,541$8.94$40.6K SaleForm 4 ↗
Sep 8, 2025Troy Edward Wilson
President & CEO, Director
KURA
Kura Oncology, Inc.
Buy50,000$8.20$410.0K BuyForm 4 ↗
Aug 13, 2025Troy Edward Wilson
President and CEO, Director
KURA
Kura Oncology, Inc.
Buy13,494$6.64$89.6K BuyForm 4 ↗

The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:12 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances